Blocking an Alcohol Effect With a CB1 Agonist Did Not Prove CB1 Mediated That Effect
A CB1 agonist prevented an ethanol-related increase in GABA release in a rat amygdala experiment, yet other comparisons argued against direct CB1 mediation of ethanol’s effect. Pharmacological opposition and pathway dependence are different findings.
The experiment tested interacting interventions
Varodayan and colleagues studied GABAergic transmission in rat central-amygdala preparations. Acute ethanol increased GABA release in both alcohol-naive and previously exposed groups.
CB1 activation prevented that increase. However, effects of the CB1 antagonist AM251 and ethanol were additive, and antagonism did not eliminate the ethanol response.
An intervention can oppose an effect through another route
A compound that reduces a response may act on a converging regulatory process rather than on the mechanism through which the original stimulus acted. The antagonist and combined-intervention comparisons help distinguish these possibilities.
The authors therefore separated a strong CB1 influence on GABA transmission from a claim that ethanol required CB1 signaling to produce its acute effect.
Do not generalize from the slice to human protection
These were rat neural preparations and pharmacological manipulations, not a trial showing that cannabis protects a person from alcohol impairment. WIN 55,212-2 was an experimental agonist, not a cannabis product.
The useful mechanistic lesson is to evaluate the complete intervention pattern. Prevention by one drug is informative, but does not alone prove mediation of another drug’s effect.
Related: Interpreting cannabis tolerance claims.
Research cited
Varodayan FP; Soni N; Bajo M; Luu G; Madamba SG; Schweitzer P; Parsons LH; Roberto M Addiction biology · 2016 · 21(4):788 PMID 25940135 · DOI 10.1111/adb.12256. Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala..
